Remove 2010 Remove Health Technology Remove Medical Technology
article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Christopher Riley is a forward-thinking, financially astute finance and operation’s executive with talent for re-engineering, building, and profitably growing businesses to achieve significant shareholder value in medical technology and consumer product markets for multinational & entrepreneurial organizations.

article thumbnail

The Venture Valkyrie’s Next AdVenture

Health Populi

While she’s best-known for being a very visible woman in health-technology investing and building venture funds, Lisa is social media savvy well beyond the profiles of those in her tech-investing peer group. Lisa started the Venture Valkyrie blog in 2010. So the apple didn’t fall too far from the paternal tree.